study was provided by the Columbia University Department of Ophthalmology。
Background:Corneal collagen crosslinking(CXL)is a widely used treatment for halting the progression of keratoconus.Although initial studies of CXL were performed with a riboflavin solution containing dextran,recent pr...
Background:Corneal cross-linking(CXL)using ultraviolet light-A(UV-A)and riboflavin is a technique developed in the 1990’s to treat corneal ectatic disorders such as keratoconus.It soon became the new gold standard in...